Anivive (7/21/2021)

CB Partner Webinar {{webinarsregistrationpage::webinar_title}} true {{webinarsregistrationpage::race_approved_pending}} 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Anivive {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

Do you wish you could do more for your canine lymphoma patients? There’s good news—the best practices for diagnosing and treating canine lymphoma are moving forward at a rapid pace, and general practitioners can do more than ever to help dogs with lymphoma. Join veterinary oncologist Dr. Craig Clifford, director of clinical studies at Hope Veterinary Specialists/BluePearl Malvern, for this webinar to learn about a novel treatment option, LAVERDIA™-CA1 (verdinexor), and how it may fit in at your clinic. The latest techniques for staging and grading lymphoma and tips for collaborating with local specialists on treatment plans will also be shared.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} How a new class of drugs, SINE inhibitors, work How LAVERDIA-CA1 differs from multiagent chemotherapy Current clinical applications for LAVERDIA-CA1 Techniques to diagnose, stage, and grade canine lymphoma Best practices for collaborating with a veterinary oncologist on patient care {{webinarsregistrationpage::what_youll_learn_bullet_6}} Company Description

Anivive is a veterinary pharmaceutical company that fuses medicine and software to accelerate the discovery, development, and commercialization of treatments for unmet medical needs. Our commitment to using software to more effectively and efficiently develop much-needed pet therapeutics helped bring LAVERDIA-CA1 and expand access to cancer care.

In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.